Stock Screener App

Gratuito -

Installare

21.03

0.28% -0.04

Innoviva Inc (INVA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Storia dei dividendi

Innoviva Inc Borsa (INVA) Ultime notizie

Cantor Fitzgerald reiterates Innoviva stock rating at overweight - Investing.com

NewEdge Wealth LLC Acquires New Stake in Innoviva, Inc. $INVA - MarketBeat

Innoviva, Inc. (NASDAQ:INVA) Receives Average Rating of "Hold" from Brokerages - MarketBeat

Innoviva (INVA) Snapshot: Posts a 2.23% Loss to $21.00 in Latest Trading; the Session Ends Within the Reported Technical Boundaries on the DayWedge Breakout - vinanet.vn

70,000 Shares in Innoviva, Inc. $INVA Purchased by Chase Investment Counsel Corp - MarketBeat

Innoviva’s Earnings Swing And Buyback Might Change The Case For Investing In Innoviva (INVA) - simplywall.st

Innoviva, Inc.: Target Price Consensus and Analysts Recommendations | INVA | US45781M1018 - marketscreener.com

Bank of America Corp DE Has $37.75 Million Stake in Innoviva, Inc. $INVA - MarketBeat

Innoviva (INVA) Holds Near $20.87 After Modest 0.29% GainSuperTrend - vinanet.vn

Innoviva Inc (INVA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Innoviva, Inc. (INVA) Stock Forecasts - Yahoo! Finance Canada

Innoviva (INVA) Holds Near $20.81 as Biopharma Royalty Stock Stays RangeboundVolatility Smile - vinanet.vn

HC Wainwright Issues Positive Forecast for Innoviva Earnings - MarketBeat

Three Innoviva therapies named finalists for Prix Galien award By Investing.com - Investing.com Australia

Three Innoviva therapies named finalists for Prix Galien award - Investing.com

Designated Finalists for the 2026 Prix Galien USA Best Pharmaceutical Product Award - Business Wire

Innoviva, Inc. (INVA) Stock Analysis: Uncovering a 69% Potential Upside in the Biotechnology Sector - DirectorsTalk Interviews

How (INVA) Movements Inform Risk Allocation Models - Stock Traders Daily

Innoviva (INVA) Holds Steady at $20.68: Key Support and Resistance in FocusVolume Oscillator - vinanet.vn

Does Innoviva’s Q2 Loss and Buyback-Fueled EPS Shift Change The Bull Case For INVA? - webull.com

Innoviva stock price target reiterated at $46 by H.C. Wainwright - Investing.com Nigeria

Innoviva Stock Price Forecast. Should You Buy INVA? - StockInvest.us

Innoviva Inc (INVA) Stock News Today - TradingKey

How Innoviva’s Q2 Loss and Aggressive Buybacks Could Reshape Capital Allocation for INVA Investors - Yahoo Finance

Cantor Fitzgerald Maintains Innoviva(INVA.US) With Buy Rating, Raises Target Price to $34 - Moomoo

Innoviva (INVA) Stock Can Revenue Growth Offset A Sharp Profit Reversal - webull.com

Cantor Fitzgerald Lowers Innoviva (NASDAQ:INVA) Price Target to $34.00 - MarketBeat

INVA Q1 2026 Earnings: Significant EPS Miss Contrasts With Positive Stock MomentumTrough Earnings Signal - vinanet.vn

Innoviva: The Royalty Decline Is Real, But The Valuation Is Too Pessimistic (NASDAQ:INVA) - Seeking Alpha

BTIG Maintains Innoviva(INVA.US) With Buy Rating, Maintains Target Price $42 - Moomoo

Innoviva (NASDAQ:INVA) Announces Quarterly Earnings Results, Misses Expectations By $1.58 EPS - MarketBeat

Innoviva Reports Second Quarter 2026 Financial Results; Highlights Recent Company Progress - BioSpace

Innoviva (INVA) Q2 Earnings and Revenues Top Estimates - Yahoo Finance

Innoviva: Q2 Earnings Snapshot - Barchart.com

Innoviva, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView

Innoviva, Inc. Q2 2026: Revenue $119.6M, EPS $(1.14) — 10-Q Summary - tradingview.com

Innoviva reports Q2 2026 revenue $119.6M, net loss $83.4M on investment markdowns - TradingView

Earnings Flash (INVA) Innoviva, Inc. Reports Q2 Revenue $119.6M, vs. FactSet Est of $111.0M - marketscreener.com

Tranche Update on Innoviva, Inc.'s Equity Buyback Plan announced on November 5, 2025. - marketscreener.com

BRIEF-Innoviva Q2 Royalty Revenue USD 56.334 Million - TradingView

Innoviva, Inc. (INVA) Stock Analysis: Biotech Powerhouse With 70% Upside Potential - DirectorsTalk Interviews

Innoviva Inc. (INVA) Pulls Back 0.95% to $20.77 as Traders Eye Key Support ZoneSwing Entry Signals - dars.gov.et

Empowered Funds LLC Purchases 93,424 Shares of Innoviva, Inc. $INVA - MarketBeat

Innoviva, Inc. $INVA Shares Sold by Healthcare of Ontario Pension Plan Trust Fund - MarketBeat

INVA Q1 2026 Earnings: EPS Misses Consensus by Wide Margin, Stock Declines 1.18%Earnings Cycle Report - Vinanet

Innoviva, Inc. Revenue Breakdown – NASDAQ:INVA - TradingView

THRX5561968 Bond Coupon Profile — Rate & Payments - TradingView

Innoviva Inc (INVA) Institutional Confidence - TradingKey

Innoviva (INVA) Projected to Release Earnings on Wednesday - MarketBeat

Innoviva earnings up next: Can LYNX platform pivot pay off? By Investing.com - Investing.com Nigeria

Innoviva (INVA): Affordable Growth Stock at a Reasonable Valuation - ChartMill

Innoviva Inc (INVA) Valuation: PE, PB & Fair Value Analysis - TradingKey

INVA|Innoviva Inc|Price:20.970|Chg%:-0.250 - TradingKey

Innoviva Inc (INVA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Innoviva Inc (INVA) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com

Innoviva Inc (INVA) Earnings Date & Reports & Earnings News - tradingkey.com

Thai FDA approves Dr Reddy’s gonorrhoea antibiotic - pharma.economictimes.indiatimes.com

Innoviva Inc (INVA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Innoviva Market Sentiment - Benzinga España

Innoviva Inc. (INVA) Gains Ground as Price Approaches Key Resistance LevelVWAP Bounce - dars.gov.et

Innoviva Inc (INVA) Balance Sheet - TradingKey

INSM

$124.04

1.35%

RPRX

$61.01

0.47%

BNTX

$113.17

2.89%

ALNY

$232.48

1.72%

ONC

$371.63

0.67%

RVMD

$210.77

0.61%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters